Fennec Pharmaceuticals Inc.
FENC
$11.29
-$0.06-0.53%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 41.25M | 40.18M | 36.79M | 21.95M | 18.71M |
| Total Receivables | 23.27M | 18.76M | 23.22M | 19.34M | 17.50M |
| Inventory | 2.37M | 1.86M | 1.57M | 2.48M | 2.20M |
| Prepaid Expenses | 3.64M | 3.46M | 3.74M | 1.40M | 1.42M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.98M | 2.62M | 1.73M | 898.00K | 965.00K |
| Total Current Assets | 72.50M | 66.88M | 67.04M | 46.06M | 40.79M |
|
|
|||||
| Total Current Assets | 72.50M | 66.88M | 67.04M | 46.06M | 40.79M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.25M | 4.94M | 3.51M | 3.20M | 4.08M |
| Total Assets | 75.75M | 71.82M | 70.55M | 49.26M | 44.88M |
|
|
|||||
| Total Accounts Payable | 5.52M | 6.28M | 4.64M | 5.87M | 5.94M |
| Total Accrued Expenses | 3.70M | 3.06M | 5.64M | 3.70M | 2.23M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 3.18M | 248.00K | 248.00K | 248.00K | 248.00K |
| Total Other Current Liabilities | 3.18M | 248.00K | 248.00K | 248.00K | 248.00K |
| Total Current Liabilities | 12.39M | 9.59M | 10.52M | 9.82M | 8.41M |
|
|
|||||
| Total Current Liabilities | 12.39M | 9.59M | 10.52M | 9.82M | 8.41M |
| Long-Term Debt | -- | -- | -- | 19.38M | 19.36M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 20.92M | 24.56M | 24.56M | 24.56M | 24.56M |
| Total Liabilities | 33.31M | 34.15M | 35.08M | 53.75M | 52.34M |
|
|
|||||
| Common Stock & APIC | 268.45M | 265.65M | 263.65M | 218.90M | 215.29M |
| Retained Earnings | -227.25M | -229.22M | -229.42M | -224.64M | -224.00M |
| Treasury Stock & Other | 1.24M | 1.24M | 1.24M | 1.24M | 1.24M |
| Total Common Equity | 42.44M | 37.68M | 35.47M | -4.49M | -7.46M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 42.44M | 37.68M | 35.47M | -4.49M | -7.46M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 42.44M | 37.68M | 35.47M | -4.49M | -7.46M |
|
|
|||||